Improvement of lymphocyte proliferation in human immunodeficiency virus infection after recombinant interleukin-2 treatment

Scand J Infect Dis. 1999;31(5):437-42. doi: 10.1080/00365549950163950.

Abstract

In this study, the effect of recombinant interleukin-2 (rIL-2) on the function of peripheral blood mononuclear cells (PBMC) from human immunodeficiency virus (HIV)-infected patients was examined. Using polymerase chain reaction (PCR), an impaired ability of PBMC from 8 patients to respond upon mitogen stimulation with expression of IL-2 and IL-2 receptor (IL-2R) messenger ribonucleic acid (mRNA) was found compared with healthy donors (p = 0.02 and p = 0.05, respectively). Flow cytometry was used to determine the expression of p55 interleukin-2 alpha-receptor (CD25) after phytohaemagglutinin (PHA)-stimulation. Induced CD25 expression in response to stimulation was lower in patient cells than in donor cells (in CD4+ (p = 0.01) and in CD8+ (p = 0.03)). After rlL-2 treatment, the functionality of ex vivo expanded PBMC from patients was restored to the level found in donors. Finally, the induced gene expressions for IL-2 and IL-2R were positively correlated (p < 0.0001), suggesting that the activation of the IL-2 and IL-2R genes in humans may share a common activation pathway, as has been found in monkeys infected by simian immunodeficiency virus (SIV). These results indicate the existence of a reversible IL-2 and IL-2R defect at the pretranscriptional or transcriptional level in PBMC from patients. This may help explain the T-cell anergy found during HIV-infection.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD4 Lymphocyte Count
  • DNA, Complementary / biosynthesis
  • Female
  • Flow Cytometry
  • HIV Infections / immunology*
  • HIV Infections / therapy*
  • Humans
  • Interleukin-2 / genetics
  • Interleukin-2 / therapeutic use*
  • Leukocytes, Mononuclear / drug effects*
  • Lymphocytes / drug effects*
  • Male
  • Middle Aged
  • Phytohemagglutinins / pharmacology
  • Polymerase Chain Reaction
  • RNA, Messenger / drug effects
  • RNA, Messenger / immunology
  • Receptors, Interleukin-2 / drug effects*
  • Recombinant Proteins

Substances

  • DNA, Complementary
  • Interleukin-2
  • Phytohemagglutinins
  • RNA, Messenger
  • Receptors, Interleukin-2
  • Recombinant Proteins